GeorgeZ.FaddaMDFACP

Nephrology • La Mesa, CA

Nephrology attending/consultant

Join to view full profile

Dr. Fadda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fadda's full profile

Already have an account?

Office
8851 Center Dr
Ste 505
La Mesa, CA 91942
Phone+1 619-461-3880

Fax+1 619-461-3895

Summary

Dr. George Fadda is a nephrologist in San Diego, CA and is affiliated with multiple hospitals in the area, including UCSD-East Hospital Medical Center and Sharp Grossmont Hospital. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 34 years. He also speaks multiple languages, including French and Arabic. He is experienced in hypertension, chronic kidney disease, and renal transplantation. He has more than 60 publications and over 500 citings.

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Nephrology, 1986 - 1988
University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1985 - 1986
American University of Beirut Faculty of MedicineClass of 1983

Certifications & Licensure

CA State Medical License 1988 - 2026
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

San Diego Top Physician San Diego, 2000-2015, 2017
Top Doctors:San Diego Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients Start of enrollment: 2011 Sep 01
Completed
Phase 3
Safety Study of GCS-100 to Treat Chronic Kidney Disease Start of enrollment: 2013 Jan 01
Completed
Phase 1
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI Start of enrollment: 2018 Jul 09
Active, not recruiting
Phase 2
A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON Start of enrollment: 2019 May 29
Terminated
Phase 3
A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2020 Oct 13
Completed
Phase 1
Study of Suramin in Subjects With Furosemide-Resistant AKI Start of enrollment: 2020 Nov 13
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven Fishbane
Kidney360. 2024-05-01
3 citations
Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients.
Michael J Germain, Subir K Paul, George Fadda, Varshasb Broumand, Andy Nguyen
BMC Nephrology. 2022-11-11
5 citations
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol.
George Z. Fadda, Michael J. Germain, Varshasb Broumand, Andy Nguyen, November McGarvey
American Journal of Nephrology. 2021-10-27

Research History

Founder of California Institute of renal research in San DiegoSubsidiary of Balboa Nephrology Medical Group, San Diego, CA2000 - Present

Other Languages

Arabic, French